Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Janux Therapeutics (JANX) Receivables - Other: 2023-2024

Historic Receivables - Other for Janux Therapeutics (JANX) over the last 2 years, with Dec 2024 value amounting to $5.4 million.

  • Janux Therapeutics' Receivables - Other rose 41.78% to $6.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.3 million, marking a year-over-year increase of 41.78%. This contributed to the annual value of $5.4 million for FY2024, which is 149.01% up from last year.
  • As of FY2024, Janux Therapeutics' Receivables - Other stood at $5.4 million, which was up 149.01% from $2.2 million recorded in FY2023.
  • Janux Therapeutics' 5-year Receivables - Other high stood at $5.4 million for FY2024, and its period low was $2.2 million during FY2023.
  • Its 2-year average for Receivables - Other is $3.8 million, with a median of $3.8 million in 2023.
  • Data for Janux Therapeutics' Receivables - Other shows a peak YoY surged of 149.01% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Janux Therapeutics' Receivables - Other stood at $2.2 million in 2023, then spiked by 149.01% to $5.4 million in 2024.